NCT07747675 · NOT YET RECRUITING

Cognitive Intervention for Cognitive Impairment

This trial is testing whether a structured brain-training program — eight weekly one-hour sessions over about two months — can improve cognitive scores in older adults aged 65 to 95 who have both mild cognitive impairment and type 2 diabetes. It uses the MoCA test to measure change. This is a Phase N/A randomized trial, meaning it is evaluating a non-drug behavioral approach rather than a medication.

You may qualify if

  • Affiliation with IMSS Aguascalientes Family Medicine Unit (UMF) No. 7; age 65 to 95 years; male or female; known diagnosis of type 2 diabetes mellitus; any level of education; any occupation; presence of mild cognitive impairment; availability to attend cognitive intervention sessions; and signing of informed consent.

You're excluded if

  • Patients with disabling hearing and/or visual impairments, patients with paralysis, and patients with severe psychiatric illness.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-08-05

View full record on ClinicalTrials.gov

All APOE4 clinical trials